Protecting vulnerable research subjects in critical care trials: Enhancing the informed consent process and recommendations for safeguards

Annals of Intensive Care

Volumn 1, Issue 1, 2011, Pages

  Silverman, Henry ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL RESEARCH; HUMAN; INFORMED CONSENT; INTENSIVE CARE; LEGAL COMPETENCE; MEDICAL RESEARCH; PATIENT DECISION MAKING; PATIENT SAFETY; PRIORITY JOURNAL; PROTECTION; RESEARCH ETHICS; REVIEW; VULNERABLE POPULATION;

EID: 84858013647     PISSN: None     EISSN: 21105820     Source Type: Journal    
DOI: 10.1186/2110-5820-1-8     Document Type: Review

References (58)

1. National Bioethics Advisory Commission (NBAC): Research involving persons with mental disorders that may affect decision-making capacity. 2 vols. Rockville, MD: U.S. Government Printing Office; 1998.
2. World Health Organization: Declaration of Helsinki - ethical principles for medical research involving human subjects. 2008 [http://www.wma.net/ en/2030publications/2010policies/b2013/index.html], [Accessed February 2011].
3. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research: The Belmont Report: ethical principles and guidelines for the protection of human subjects of research. Washington, D.C.: U.S. Government Printing Office; 1979.
4. Council for International Organizations of Medical Sciences (CIOMS): International ethical guidelines for biomedical research involving human subjects. Geneva, Switzerland: CIOMS; 2002.
5. Council of Europe: Convention for the Protection of Human Rights and Dignity of the Human Being with Regard to the Application of Biology and Medicine: Convention on Human Rights and Biomedicine. 1997 [http://conventions.coe.int/Treaty/en/Treaties/html/164.htm].
6. Bonnie RJ: Research with cognitively impaired subjects. Unfinished business in the regulation of human research. Arch Gen Psychiatry 1997, 54:117-120.
7. Department of Health and Human Services: Federal Policy for the Protection of Human Subjects, 45 CFR 46 Subpart A. Federal Register 1991, 56:28016.
8. Silverman HJ, Druml C, Lemaire F, Nelson R: The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis. Intensive Care Med 2004, 30:1723-1729.
9. Liddell K, Bion J, Chamberlain D, Druml C, Kompanje E, Lemaire F, Menon D, Vrhovac B, Wiedermann CJ: Medical research involving incapacitated adults: implications of the EU Clinical Trials Directive 2001/ 20/ED. Medical Law Review 2006, 14:367-417.
10. Ng Gong M, Winkel G, Rhodes R, Richardson LD, Silverstein JH: Surrogate consent for research involving adults with impaired decision making: Survey of Institutional Review Board practices. Crit Care Med 2010, 38:2156-2154.
11. Office of Human Research Protections (OHRP): Compliance Determination Letters. Rockville, MD 2002 [http://www.hhs.gov/ohrp/compliance/letters/ 2002.html], [Accessed April 22, 2011].
12. Schaeffer MH, Krantz DS, Wichman A, et al: The Impact of Disease Severity on the Informed Consent Process in Clinical Research. American Journal of Medicine 1996, 100:261-268.
13. Hustey FM, Meldon SW: The prevalence and documentation of impaired mental status in elderly emergency department patients. Ann Emerg Med 2002, 39:248-253.
14. Smithline HA, Mader TJ, Crenshaw BJ: Do patients with actue medical conditions have the capacity to give informed consent for emergency medicine research? Ann Emerg Med 1999, 6:776-780.
15. Pisani MA, McNicoll L, Inouye SK: Cognitive impairment in the intensive care unit. Clin Chest Med 2003, 24:727-737.
16. Raymont V, Bingley W, Buchanan A, et al: Prevalence of mental incapacity in medical inpatients and associated risk factors: Cross-sectional study. Lancet 2004, 364:1421-1427.
17. Schultz AL, Geraldine PP, Ensinck JW: Are research subjects really informed? Western J Med 1975, 123:76-80.
18. Miller CH, Searight R, Grable D, et al: Comprehension and recall of the informational content of the informed consent document: an evaluation of 168 patients in a controlled clinical trial. J Clin Res Drug Dev 1994, 8:237-248.
19. Williams B, French J, White H, for the HERO-2 consent substudy investigators: Informed consent during the clinical emergency of acute myocardial infarction (HERO-2 consent substudy): a prospective observational study. Lancet 2003, 361:918-922.
20. Chenaud C, Merlani P, Luyasu S, Ricou B: Informed consent for research obtained during the intensive care unit stay. Crit Care Med 2006, 10:R170.
21. Miller FG, Rosenstein DL: The therapeutic orientation to clinical trials. N Engl J Med 2003, 348:1383-1386.
22. Appelbaum PS, Roth LH, Lidz C: The therapeutic misconception: Informed consent in psychiatric research. Int J Law Psychiatry 1982, 5:3-4.
23. Appelbaum PS, Lidz CW, Grisson T: Therapeutic misconception in clinical research: frequency and risk factors. IRB Ethics Human Res 2004, 26:1-8.
24. Daugherty CK, Banik DM, Janish L, Ratain MJ: Quantitative analysis of ethical issues in phase I trials: a survey interview study of 144 advanced cancer patients. IRB 2000, 22:6-13.
25. Joffe S, Cook EF, Cleary PD, Clark JW, Weeks JC: Quality of informed consent in cancer clinical trials: a cross-sectional survey. Lancet 2001, 358:1772-1777.
26. Henderson GE, Easter MM, Zimmer C, King Nancy MP, Davis A, Rothschild BB, Churchill LR, Wilfond BS, Nelson DK: Therapeutic misconception in early phase gene transfer trials. Soc Sci Med 2006, 62:239-253.
27. Durand-Zaleski IS, Alberti C, Durieux P, Duval X, Gottot S, Ravaud Ph, Fainotti S, Vincent-Genod C, Moreau D, Amiel P: Infomred consent in clinical research in France: assessment and factors associated with therapeutic misconception. J Med Ethics 2008, 34:e16-e16.
28. de Melo-Martin I, Ho A: Beyond informed consent: the therapeutic misconception and trust. J Med Ethics 2009, 34:202-205.
29. Lidz WW, Appelbaum PS: The therapeutic misconception: problems and solutions. Med Care 2002, 40:V55-V63.
30. Instone SL, Mueller MR, Gilbert TL: Therapeutic discourse among nurses and physicians in controlled clinical trials. Nursing Ethics 2008, 15:803-812.
31. Miller M: Phase I cancer trials. A collusion of misunderstanding. Hastings Center Report 2000, 30:34-43.
32. Olver IN, Buchanan L, Laidlaw C, et al: The adequacy of consent forms for informing patients entering oncological clinical trials. Ann Oncol 1995, 6:867-870.
33. Tankanow RM, Sweet BV, Weiskopf JA: Patients' perceived understanding of informed consent in investigational drug studies. Am J Hosp Pharm 1992, 49:633-635.
34. Silverman HJ, Hull SC, Sugarman J: Variability among institutional review boards' decisions within the context of a multicenter trial. Crit Care Med 2001, 29:235-241.
35. Grossman SA, Piantadosi S, Covahey C: Are informed consent forms that describe clinical oncology research protocols readable by most patients and their families? J Clin Oncol 1994, 12:2211-2215.
36. Mader FJ, Plays SJ: Emergency medicine research consent form readability assessment. Ann Emerg Med 1997, 29:534-539.
37. Paasche-Orlow MK, Taylor HA, Brancati FL: Readability standards for informed-consent forms as compared with actual readability. N Engl J Med 2003, 348:721-726.
38. Padberg RM, Flach J: National efforts to improve the informed consent process. Semin Oncol Nurs 1999, 15:138-144.
39. Dresden GM, Levitt A: Modifying a standard industry clinical trial consent form improves patient information retention as part of the informed consent process. Acad Emerg Med 2001, 8:248-252.
40. Young DR, Hooker DT, Freeberg FE: Informed consent documents: increasing comprehension by reducing reading level. IRB 1990, 12:1-6.
41. Silverman HJ, Luce JM, Lanken PN, Morris AH, Harabin AL, Oldmixon CF, Thompson BT, Bernard GR, for the NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network (ARDSnet): Recommendations for informed consent forms for critical care clinical trials. Crit Care Med 2005, 33:867-882.
42. Flory J, Emanuel E: Interventions to improve research participants' understanding in informed consent for research. A systematic review. JAMA 2004, 292:1593-1601.
43. Titus SL, Keane MA: Do you understand? An ethical assessment of researchers' description of the consenting process. J Clin Ethics 1996, 7:60-68.
44. Johnson-Greene D: Informed consent issues in traumatic brain injury research: current status of capacity assessment and recommendations for safeguards. J Head Trauma Rehabil 2010, 25:145-150.
45. Silverman HJ, Luce JM, Schwartz J: Protecting subjects with decisional impairment in research. The need for a multifaceted approach. Am J Respir Crit Care Med 2004, 169:10-14.
46. Sturman ED: The capacity to consent ot treatment and research: a review of standardized assessment tools. Clin Psychol Rev 2005, 25:954-974.
47. Jeste DV, Palmer BW, Appelbaum PS, Golshan S, Glorioso D, Dunn LB, Kim K, Meeks T, Kraemer HC: A new brief instrument for assessing decisional capacity for clinical research. Arch Gen Psychiatry 2007, 64:966-974.
48. Gainotti S, Imperatori SF, Spila-Alegiani S, Maggiore L, Galeotti F, Vanacore N, Petrini C, Raschetti R, Mariani C, Clerici F: How are the interests of incapacitated research participants protected through legislation? An Italian study on legal agency for dementia patients. PLoS One 2010, 5:e11150.
49. Sulmasy DP, Terry PB, Weisman CS, Miller DJ, Stallings RY, Vettese MA, KB H: The accuracy of substituted judgments in patients with terminal diagnoses. Ann Intern Med 1998, 128:621-629.
50. Coppolino M, Ackerson L: Do surrogate decision makers provide accurate consent for intensive care research? Chest 2001, 119:603-612.
51. Jones C, Skirrow P, Griffiths R, Humphris G, Ingleby S, Eddleston J, Waldmann C, Gager M: Post-traumatic stress disorder-related symptoms in relatives of patients following intensive care. Intensive Care Med 2004, 30:456-460.
52. Pochard F, Azoulay E, Chevret S, Lemaire F, Hubert P, Canoui P, Grassin M, Zittoun R, Lle Gall JR, Dhainaut JF, et al: Symptoms of anxiety and depression in family members of intensive care unit patients: ethical hypothesis regarding decision-making capacity. Crit Care Med 2001, 29:1893-1897.
53. Anonymous: Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the member states relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Off J Eur Communities 2001, L121:33-44.
54. Tri-Council Policy Statement: Ethical conduct for research involving humans. 2nd Edition. 1998 [http://www.pre.ethics.gc.ca/pdf/eng/tcps2/ TCPS_2_FINAL_Web.pdf].
55. Wendler D, Prasad K: Core safeguards for clinical research with adults who are unable to consent. Ann Intern Med 2001, 135:514-523.
56. Keyserlingk EW, Kogan GK, Gauthier S: Proposed guidelines for the participation of persons with dementia as research subjects. Perspect Biol Med 1995, 38:319-361.
57. Karlawish JHT: Research involving cognitively impaired adults. N Engl J Med 2003, 348:1289-1392.
58. Weijer C: The ethical analysis of risk. J Law Med Ethics 2000, 28:344-361.